ECM
BIIB icon

Endurant Capital Management’s Biogen BIIB Stock Holding History

Endurant Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,399
Closed -$4.91M – 74
2017
Q4 		$4.91M Sell
15,399
-24,418
-61% -$7.83M 1.5% 31
2017
Q3 		$12.5M Buy
39,817
+8,185
+26% +$2.42M 3.78% 2
2017
Q2 		$8.58M Buy
31,632
+20,400
+182% +$5.39M 2.43% 15
2017
Q1 		$3.07M Buy
11,232
+1,700
+18% +$481K 0.99% 35
2016
Q4 		$2.7M Sell
9,532
-7,900
-45% -$2.34M 1.12% 35
2016
Q3 		$5.46M Sell
17,432
-3,100
-15% -$918K 2.02% 18
2016
Q2 		$4.96M Sell
20,532
-12,200
-37% -$3.22M 1.66% 20
2016
Q1 		$8.52M Buy
32,732
+1,200
+4% +$317K 2.76% 10
2015
Q4 		$9.66M Buy
31,532
+17,920
+132% +$5.15M 3.23% 6
2015
Q3 		$3.97M Sell
13,612
-500
-4% -$165K 1.33% 27
2015
Q2 		$5.7M Buy
14,112
+5,300
+60% +$2.13M 1.68% 18
2015
Q1 		$3.72M Sell
8,812
-800
-8% -$315K 1.23% 29
2014
Q4 		$3.26M Buy
+9,612
New +$3.11M 1.28% 23

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Endurant Capital Management's BIIB Position: Q1 2018 in Review

Endurant Capital Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 15,399 shares — an estimated $4.91M sold.

Endurant Capital Management first reported a position in BIIB in Q4 2014 and held it in 13 quarters. The position peaked at $12.5M in Q3 2017. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Endurant Capital Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Endurant Capital Management sold 15,399 Biogen shares in Q1 2018, an estimated $4.91M.
  • Endurant Capital Management first reported a position in Biogen in Q4 2014 and held it in 13 quarters.
  • Endurant Capital Management's Biogen position peaked at $12.5M in Q3 2017.
  • 1,102 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Endurant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.